Mutual Fund Ownership
Ownership as on: Tue, 16 Apr, 2024

DSP Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)139.43
% of AUM5.93%

Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)23.67
% of AUM3.38%

Kotak Small Cap Growth

3/5
Equity
Amount Invested (Cr.)338.91
% of AUM2.44%

WhiteOak Capital Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)2.48
% of AUM2.28%

Union Small Cap Fund Regular Growth

3/5
Equity
Amount Invested (Cr.)28.46
% of AUM2.20%

FAQs about Alembic Pharmaceuticals share price

Alembic Pharmaceuticals is trading at 963.65 as on Tue Apr 16 2024 09:56:58. This is -0.51% lower as compared to its previous closing price of 968.60.

The market capitalization of Alembic Pharmaceuticals is 18941.81 Cr as on Tue Apr 16 2024 09:56:58.

The average broker rating on Alembic Pharmaceuticals is Hold. The breakup of analyst rating is given below -

  • 2 analysts have given a strong buy rating
  • 2 analysts have given a buy rating
  • 6 analysts have given a hold rating
  • 2 analysts have given a sell rating
  • 1 analysts have given a strong sell rating

The 52 wk high for Alembic Pharmaceuticals is 1093.05 whereas the 52 wk low is 516.60

Alembic Pharmaceuticals can be analyzed on the following key metrics -

  • TTM P/E: 25.30
  • Sector P/E: 27.85
  • Dividend Yield: 0.83%
  • D/E ratio: -

Alembic Pharmaceuticals reported a net profit of 341.97 Cr in 2023.

Recommended For You
Trending Stocks
3,647.05+45.50(1.26%)
2,220.90+26.30(1.20%)
1,509.40+14.45(0.97%)
1,414.75-53.55 (-3.65%)
1,490.75-48.05 (-3.12%)